Dow’s Healthcare-Fueled Surge Leaves Commodities in the Dust as Rotation Intensifies

If you blinked, you missed it: the Dow just notched another all-time high, and it wasn’t tech or commodities leading the charge. It was healthcare and financials, two sectors that have spent most of the AI mania in the market’s waiting room. The S&P 500 edged higher, but the real story is the rotation, out of tech, out of commodities, and into the parts of the market that traders had all but left for dead. The tape says it all. The Dow added 875 points, while the S&P 500’s gains were modest and the Nasdaq looked like it needed a defibrillator. Commodities, tracked by DBC, are stuck at $29.89, flatlining for days as oil and metals lose their grip on the narrative. Tech, via XLK at $193.13, is treading water after months of relentless inflows.

The news cycle is full of hot takes about AI fatigue and the end of the tech supercycle. Barron’s points to healthcare stocks jumping more than 3% as AI darlings finally cool off. CNBC’s Jim Cramer is practically shouting about investors’ ‘huge appetite’ for stocks, just not the ones that led the last leg higher. The macro backdrop is equally schizophrenic. US job openings are at their highest in two years, but the market is acting like it’s already priced in. The Fed is still weighing rate hikes, but the bond market is yawning. Commodities, once the inflation hedge du jour, are now the wallflowers at the risk party.

Zoom out and the rotation is glaring. May saw US stocks gain +5.26%, with world stocks up +3.90%. Commodities gave back ground, and the S&P 500’s cyclically adjusted P/E and market cap-to-GDP ratios are near all-time highs (Seeking Alpha). The old playbook, buy tech, short everything else, isn’t working. Healthcare and financials are back in vogue, and the only thing flatlining harder than DBC is the VIX.

For traders, the opportunity is in the rotation. The easy money in tech is gone, and the risk-reward in commodities is dead money unless you like watching paint dry. The Dow’s outperformance is a sign that the market wants defensives and yield, not moonshots. The question is whether this is the start of a new trend or just a dead cat bounce for the old economy.

Strykr Watch

Technically, the Dow is in blue-sky territory, with no overhead resistance. Watch for support at recent breakout levels and keep an eye on sector flows, healthcare and financials are leading, while tech and commodities lag. XLK is stuck at $193.13, with support at $190 and resistance near $200. DBC is glued to $29.89, with no real momentum in either direction. RSI readings across sectors are mixed, with healthcare flashing overbought and tech drifting toward neutral. Moving averages are flattening in commodities, signaling a lack of conviction.

The risk is that this rotation is a head fake, driven by short-term flows rather than fundamentals. If tech regains its footing or commodities catch a bid on macro surprises, the rotation could unwind fast. But for now, the trend is your friend, until it isn’t.

The bear case is that elevated valuations and a lack of earnings growth will eventually catch up to equities, especially if the Fed surprises hawkish. The bull case? As long as money keeps rotating rather than leaving the market, the path of least resistance is higher. For traders, the play is to ride the rotation but keep stops tight.

Opportunities abound for those willing to pivot. Long healthcare and financials on dips, fade tech rallies into resistance, and avoid commodities until volatility returns. The real alpha is in sector rotation, not broad beta exposure.

Strykr Take

The Dow’s record run is a wake-up call for traders stuck in last year’s playbook. The rotation is real, and the market is rewarding those who adapt. Stay nimble, follow the flows, and don’t get married to dead trades. The next leg higher won’t look like the last.